| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 7, 2026 | ±3.6% | -1.2% | over-priced |
| November 6, 2025 | ±2.5% | -0.7% | over-priced |
| August 7, 2025 | ±3.3% | -3.9% | under-priced |
| May 8, 2025 | ±2.8% | -1.1% | over-priced |
| November 7, 2024 | ±2.8% | -0.3% | over-priced |
| August 8, 2024 | ±3.5% | +0.1% | over-priced |
| May 9, 2024 | ±3.2% | +1.6% | over-priced |
| November 2, 2023 | ±3.5% | -1.6% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $5.41 | $3.4B | $274M |
| Q4 FY2025 | $4.38 | $3.4B | $225M |
| Q3 FY2025 | $5.17 | $3.2B | $266M |
| Q2 FY2025 | $4.56 | $3.2B | $235M |
Assurant, Inc. (AIZ) reports in 99 days, with the next report estimated for September 20, 2026. Across the last 8 reports, options priced an average ±3.1% earnings move while the stock actually moved 1.3% on average — the market has systematically over-priced AIZ's earnings risk. Fundamentals into the print: EPS up 91.2% year-over-year, revenue up 11.3%. QuantLogix's live 5-factor engine currently reads AIZ as a buy at 64/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →